- The Global Heart Defect Closure Devices market is expected to grow at a CAGR of 9 percent during the period 2013-2018.
London, 06 August 2014: TechNavio, an independent tech-focused global research firm, announced today the publication of its market research report on the Global Heart Defect Closure Devices Market 2014-2018. One major emerging trend in this market is the use of Left Atrial Appendage closure devices for heart stroke prevention in atrial fibrillation patients. The closure of LAA helps prevent blood clots migrating from the LAA opening, reducing the risk of heart stroke.
Heart defect closure devices are used for the treatment of congenital heart defects such as Patent Foramen Ovale, Left Atrial Appendage, Patent Ductus Arteriosus, Atrial Septal Defect and Ventricular Septal Defect. Heart defect closure devices form a significant part of the Structural Heart Devices segment in the cardiovascular sector.
“The Global Heart Defect Closure Devices market forms a significant part of the Interventional Cardiology Devices industry, and the market has huge opportunities to grow during the forecast period,” says Faisal Ghaus, Vice President of TechNavio Research.
To define the market conditions in the next 3-4 years, TechNavio analysts have conducted in-depth analysis of the impact of market drivers, challenges and trends featuring data on product segmentations, vendor shares, growth rate by revenue and an evaluation of the different buying criteria in the order of importance.
https://www.technavio.com/%3Cp%3EIf%20you%20are%20interested%20in%20more%…
